This page is part of the Potential Drug-Drug Interaction (PDDI) Clinical Decision Support (CDS) (FHIR IG) (v1.0.0-ballot: STU 1 Ballot 3) based on FHIR R4. . For a full list of available versions, see the Directory of published versions
Official URL: http://hl7.org/fhir/uv/pddi/ValueSet/valueset-ethacrynate | Version: 1.0.0-ballot | |||
Draft as of 2022-11-29 | Computable Name: Valueset_ethacrynate | |||
Copyright/Legal: (copyright expectations unknown) |
ValueSet containing drug identifiers for ethacrynate.
References
http://www.nlm.nih.gov/research/umls/rxnorm
Code | Display |
151689 | Edecrin |
62349 | Ethacrynate |
4108 | Ethacrynate Sodium |
4109 | Ethacrynic Acid |
211509 | Ethacrynate Sodium 50 MG Injection [Edecrin] |
1251905 | Ethacrynic Acid 25 MG Oral Tablet [Edecrin] |
1729080 | Ethacrynate Sodium 50 MG [Edecrin] |
1251904 | Ethacrynic Acid 25 MG [Edecrin] |
619260 | Ethacrynate Oral Tablet [Edecrin] |
1729081 | Ethacrynate Injection [Edecrin] |
617325 | Ethacrynate Sodium 50 MG Injection |
1251903 | Ethacrynic Acid 25 MG Oral Tablet |
1251907 | Ethacrynic Acid 50 MG Oral Tablet |
1729077 | Ethacrynate Sodium 50 MG |
1251902 | Ethacrynic Acid 25 MG |
1251906 | Ethacrynic Acid 50 MG |
617327 | Ethacrynate Oral Tablet |
1729078 | Ethacrynate Injection |
1156815 | Ethacrynate Injectable Product |
1156816 | Ethacrynate Oral Product |
1156817 | Ethacrynate Pill |
1729082 | Edecrin Injectable Product |
1173193 | Edecrin Oral Product |
1173194 | Edecrin Pill |
This value set contains 24 concepts
Expansion based on RxNorm version ??
Explanation of the columns that may appear on this page:
Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies |
System | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
Code | The code (used as the code in the resource instance) |
Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
Definition | An explanation of the meaning of the concept |
Comments | Additional notes about how to use the code |